Publication Information

{'id': 'https://openalex.org/W2325099349', 'doi': 'https://doi.org/10.1097/00001813-200104000-00009', 'title': 'Antitumor activity of XR5944, a novel and potent topoisomerase poison', 'display_name': 'Antitumor activity of XR5944, a novel and potent topoisomerase poison', 'publication_year': 2001, 'publication_date': '2001-04-01', 'ids': {'openalex': 'https://openalex.org/W2325099349', 'doi': 'https://doi.org/10.1097/00001813-200104000-00009', 'mag': '2325099349', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11335793'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001813-200104000-00009', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S158028025', 'display_name': 'Anti-Cancer Drugs', 'issn_l': '0959-4973', 'issn': ['0959-4973', '1473-5741'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5068021335', 'display_name': 'Alistair Stewart', 'orcid': 'https://orcid.org/0000-0001-8984-5146'}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Alistair J Stewart', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049488273', 'display_name': 'Prakash Mistry', 'orcid': None}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Prakash Mistry', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081285631', 'display_name': 'Wendy Dangerfield', 'orcid': None}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Wendy Dangerfield', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082619050', 'display_name': 'Douglas Bootle', 'orcid': None}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Douglas Bootle', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031429222', 'display_name': 'Mark Baker', 'orcid': 'https://orcid.org/0000-0002-6115-1502'}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mark Baker', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021299048', 'display_name': 'Barbara Kofler', 'orcid': 'https://orcid.org/0000-0002-1198-4776'}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Bettina Kofler', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028453725', 'display_name': 'Sade Okiji', 'orcid': None}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Sade Okiji', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061684371', 'display_name': 'Bruce C. Baguley', 'orcid': 'https://orcid.org/0000-0001-9943-6987'}, 'institutions': [{'id': 'https://openalex.org/I4210105931', 'display_name': 'Cancer Society of New Zealand', 'ror': 'https://ror.org/01bk8ee93', 'country_code': 'NZ', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210105931']}, {'id': 'https://openalex.org/I154130895', 'display_name': 'University of Auckland', 'ror': 'https://ror.org/03b94tp07', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I154130895']}], 'countries': ['NZ'], 'is_corresponding': False, 'raw_author_name': 'Bruce C Baguley', 'raw_affiliation_strings': ['Auckland Cancer Society Research Centre, The University of Auckland, Private Bag 92019, Auckland 1000, New Zealand.'], 'affiliations': [{'raw_affiliation_string': 'Auckland Cancer Society Research Centre, The University of Auckland, Private Bag 92019, Auckland 1000, New Zealand.', 'institution_ids': ['https://openalex.org/I4210105931', 'https://openalex.org/I154130895']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023901201', 'display_name': 'William A. Denny', 'orcid': 'https://orcid.org/0000-0001-7997-1843'}, 'institutions': [{'id': 'https://openalex.org/I4210105931', 'display_name': 'Cancer Society of New Zealand', 'ror': 'https://ror.org/01bk8ee93', 'country_code': 'NZ', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210105931']}, {'id': 'https://openalex.org/I154130895', 'display_name': 'University of Auckland', 'ror': 'https://ror.org/03b94tp07', 'country_code': 'NZ', 'type': 'education', 'lineage': ['https://openalex.org/I154130895']}], 'countries': ['NZ'], 'is_corresponding': False, 'raw_author_name': 'William A Denny', 'raw_affiliation_strings': ['Auckland Cancer Society Research Centre, The University of Auckland, Private Bag 92019, Auckland 1000, New Zealand.'], 'affiliations': [{'raw_affiliation_string': 'Auckland Cancer Society Research Centre, The University of Auckland, Private Bag 92019, Auckland 1000, New Zealand.', 'institution_ids': ['https://openalex.org/I4210105931', 'https://openalex.org/I154130895']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051183042', 'display_name': 'Peter Charlton', 'orcid': None}, 'institutions': [], 'countries': ['GB'], 'is_corresponding': True, 'raw_author_name': 'Peter A Charlton', 'raw_affiliation_strings': ['Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.'], 'affiliations': [{'raw_affiliation_string': 'Xenova Ltd, 240 Bath Road, Slough SL1 4EF, UK.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5051183042'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.492, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 54, 'citation_normalized_percentile': {'value': 0.870092, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '12', 'issue': '4', 'first_page': '359', 'last_page': '367'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12226', 'display_name': 'Neuroblastoma Research and Treatments', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/topotecan', 'display_name': 'Topotecan', 'score': 0.9226917}, {'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.8429662}, {'id': 'https://openalex.org/keywords/ic50', 'display_name': 'IC50', 'score': 0.44498068}, {'id': 'https://openalex.org/keywords/topoisomerase-inhibitor', 'display_name': 'Topoisomerase inhibitor', 'score': 0.432988}], 'concepts': [{'id': 'https://openalex.org/C2778119113', 'wikidata': 'https://www.wikidata.org/wiki/Q418817', 'display_name': 'Etoposide', 'level': 3, 'score': 0.9412514}, {'id': 'https://openalex.org/C2781209748', 'wikidata': 'https://www.wikidata.org/wiki/Q419953', 'display_name': 'Topotecan', 'level': 3, 'score': 0.9226917}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.9181045}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.8429662}, {'id': 'https://openalex.org/C2780259306', 'wikidata': 'https://www.wikidata.org/wiki/Q412197', 'display_name': 'Irinotecan', 'level': 4, 'score': 0.8148531}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.68309355}, {'id': 'https://openalex.org/C2781303535', 'wikidata': 'https://www.wikidata.org/wiki/Q18936', 'display_name': 'Doxorubicin', 'level': 3, 'score': 0.67255056}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.60261256}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.4548673}, {'id': 'https://openalex.org/C2777752497', 'wikidata': 'https://www.wikidata.org/wiki/Q286779', 'display_name': 'IC50', 'level': 3, 'score': 0.44498068}, {'id': 'https://openalex.org/C2778616834', 'wikidata': 'https://www.wikidata.org/wiki/Q281044', 'display_name': 'Topoisomerase inhibitor', 'level': 4, 'score': 0.432988}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.39658612}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.37816462}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.36308104}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.3308547}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.28767264}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.14116609}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.13841876}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.119140774}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D003110', 'descriptor_name': 'Colonic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D004250', 'descriptor_name': 'DNA Topoisomerases, Type II', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D007527', 'descriptor_name': 'Isoenzymes', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010619', 'descriptor_name': 'Phenazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D059004', 'descriptor_name': 'Topoisomerase I Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D059005', 'descriptor_name': 'Topoisomerase II Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000951', 'descriptor_name': 'Antigens, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003110', 'descriptor_name': 'Colonic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004247', 'descriptor_name': 'DNA', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004247', 'descriptor_name': 'DNA', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D004247', 'descriptor_name': 'DNA', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D004264', 'descriptor_name': 'DNA Topoisomerases, Type I', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004264', 'descriptor_name': 'DNA Topoisomerases, Type I', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D004250', 'descriptor_name': 'DNA Topoisomerases, Type II', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D004268', 'descriptor_name': 'DNA-Binding Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015536', 'descriptor_name': 'Down-Regulation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D018432', 'descriptor_name': 'Drug Resistance, Multiple', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007192', 'descriptor_name': 'Indenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007192', 'descriptor_name': 'Indenes', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D007192', 'descriptor_name': 'Indenes', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D020128', 'descriptor_name': 'Inhibitory Concentration 50', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007274', 'descriptor_name': 'Injections, Intraperitoneal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007275', 'descriptor_name': 'Injections, Intravenous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007527', 'descriptor_name': 'Isoenzymes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007527', 'descriptor_name': 'Isoenzymes', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D010619', 'descriptor_name': 'Phenazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010619', 'descriptor_name': 'Phenazines', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D010619', 'descriptor_name': 'Phenazines', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': False}, {'descriptor_ui': 'D012074', 'descriptor_name': 'Remission Induction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D014407', 'descriptor_name': 'Tumor Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001813-200104000-00009', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S158028025', 'display_name': 'Anti-Cancer Drugs', 'issn_l': '0959-4973', 'issn': ['0959-4973', '1473-5741'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11335793', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1585984676', 'https://openalex.org/W1626527928', 'https://openalex.org/W1762916040', 'https://openalex.org/W1964639478', 'https://openalex.org/W1967627122', 'https://openalex.org/W1969592907', 'https://openalex.org/W1978697462', 'https://openalex.org/W1980782542', 'https://openalex.org/W1990573114', 'https://openalex.org/W1996564028', 'https://openalex.org/W1999084982', 'https://openalex.org/W2027333133', 'https://openalex.org/W2029759544', 'https://openalex.org/W2033574754', 'https://openalex.org/W2041424676', 'https://openalex.org/W2057440410', 'https://openalex.org/W2063989721', 'https://openalex.org/W2079613111', 'https://openalex.org/W2079648026', 'https://openalex.org/W2328369261', 'https://openalex.org/W4236530034'], 'related_works': ['https://openalex.org/W3094291022', 'https://openalex.org/W2941541752', 'https://openalex.org/W2429529028', 'https://openalex.org/W2400832343', 'https://openalex.org/W2118553080', 'https://openalex.org/W2104743561', 'https://openalex.org/W2098393177', 'https://openalex.org/W2062114187', 'https://openalex.org/W1988529521', 'https://openalex.org/W1981866275'], 'abstract_inverted_index': {'Inhibitors': [0], 'of': [1, 9, 13, 37, 47, 69, 129, 167, 170, 201, 222], 'topoisomerases': [2], 'are': [3], 'widely': [4], 'used': [5], 'in': [6, 61, 64, 119, 133, 164, 188, 219], 'the': [7, 45, 147, 165, 196, 220, 239], 'treatment': [8], 'cancer,': [10], 'including': [11], 'inhibitors': [12], 'topoisomerase': [14, 24, 38, 87, 98], 'I': [15, 39, 88, 99], '(camptothecin': [16], 'analogs': [17], 'such': [18], 'as': [19, 42, 84, 92, 94], 'irinotecan': [20], 'and': [21, 23, 27, 40, 57, 63, 89, 104, 115, 143], 'topotecan)': [22], 'II': [25, 41, 90, 101], '(etoposide': [26], 'doxorubicin).': [28], 'The': [29], 'novel': [30, 252], 'bis-phenazine,': [31], 'XR5944,': [32], 'is': [33, 151, 248, 256], 'a': [34, 67, 85, 186, 249], 'joint': [35, 86], 'inhibitor': [36], 'shown': [43], 'by': [44, 111], 'stabilization': [46], 'topoisomerase-dependent': [48], 'cleavable': [49], 'complexes.': [50], 'XR5944': [51, 72, 108, 130, 156, 202, 247], 'demonstrated': [52, 132], 'exceptional': [53], 'activity': [54, 118], 'against': [55], 'human': [56, 134], 'murine': [58], 'tumor': [59, 162, 189, 217, 240], 'cells': [60, 120], 'vitro': [62], 'vivo.': [65], 'In': [66, 106, 146, 195, 224], 'range': [68], 'cell': [70, 140], 'lines': [71], '(IC50': [73], '0.04-0.4': [74], 'nM)': [75], 'was': [76, 109, 131], 'significantly': [77], 'more': [78], 'potent': [79], 'than': [80], 'TAS-103,': [81, 173], 'originally': [82], 'proposed': [83], 'inhibitor,': [91], 'well': [93, 257], 'agents': [95], 'specific': [96], 'for': [97, 207], 'or': [100, 123, 210, 231], '(topotecan,': [102], 'doxorubicin': [103], 'etoposide).': [105], 'addition,': [107], 'unaffected': [110], 'atypical': [112], 'drug': [113], 'resistance': [114], 'retained': [116], 'significant': [117], 'overexpressing': [121], 'P-glycoprotein': [122], 'multidrug': [124], 'resistance-associated': [125], 'protein.': [126], 'Antitumor': [127], 'efficacy': [128], 'carcinoma': [135], 'xenograft': [136], 'models': [137], '(H69': [138], 'small': [139], 'lung': [141], 'cancer': [142], 'HT29': [144, 148], 'colon).': [145], 'model,': [149, 198], 'which': [150], 'relatively': [152], 'unresponsive': [153], 'to': [154], 'chemotherapy,': [155], '(15': [157], 'mg/kg': [158, 181, 204, 212, 228, 234], 'i.v.,': [159, 182, 205, 213, 229, 235], 'q4d×3)': [160, 230], 'induced': [161, 185, 215], 'regression': [163, 218], 'majority': [166, 221], 'animals': [168], '(six': [169], 'eight),': [171], 'whereas': [172], 'dosed': [174], 'at': [175, 259], 'its': [176], 'maximum': [177], 'tolerated': [178, 258], 'dose': [179], '(45': [180], 'q7d×3),': [183], 'only': [184, 237], 'delay': [187], 'growth': [190, 241], 'compared': [191], 'with': [192], 'control': [193], 'animals.': [194, 223], 'H69': [197], 'low': [199], 'doses': [200], '(5': [203], 'qd×5/week': [206], '2': [208], 'weeks': [209], '10-15': [211], 'q4d×3),': [214], 'complete': [216], 'contrast,': [225], 'topotecan': [226], '(20': [227], 'etoposide': [232], '(30': [233], 'q5d×5)': [236], 'slowed': [238], 'rate.': [242], 'These': [243], 'studies': [244], 'show': [245], 'that': [246, 255], 'highly': [250], 'active': [251], 'anticancer': [253], 'agent': [254], 'efficacious': [260], 'doses.': [261]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2325099349', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-13T16:14:32.575751', 'created_date': '2016-06-24'}